What is the current market size?

The Single-Molecule Immunoassay Instrument market size was valued at approximately USD 1.2 billion in 2023, driven by demand in precision diagnostics.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, fueled by advancements in ultra-sensitive detection technologies.

What are the key drivers of market growth?

Key drivers include rising adoption in oncology research, growing demand for early disease detection, and increased R&D investments in immunoassay technologies.

What challenges does the market face?

High instrument costs, technical complexity, and limited skilled professionals hinder widespread adoption in emerging markets.

Which regions are leading the market?

North America leads due to advanced healthcare infrastructure, while Europe and Asia-Pacific show strong growth from expanding biotech sectors.

Who are the top companies in the market?

Leading firms include Quanterix, PerkinElmer, Bio-Rad, and Roche, with a focus on innovation and strategic partnerships to maintain market share.

What are the future opportunities?

Opportunities lie in expanding applications for infectious disease monitoring, leveraging AI for data analysis, and growing point-of-care testing markets.

How is technology impacting the market?

Advancements in digital microfluidics and multiplexing capabilities are enhancing assay sensitivity, enabling single-molecule detection for rare biomarkers.

What is the regulatory landscape like?

Regulatory bodies like FDA and EMA emphasize stringent validation for clinical use, while harmonized guidelines support global market expansion and standardization.

How is the market segmented?

The market is segmented by product type (instruments, reagents), application (oncology, immunology), and end-user (hospitals, research labs).

Single-Molecule Immunoassay Instrument Growth Trends & Strategic Outlook 2033

Single-Molecule Immunoassay Instrument by Application (Serum, Plasma, Cerebrospinal Fluid, Others), by Types (Desktop, Vertical), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Single-Molecule Immunoassay Instrument Market Size | CAGR 12.3 Forecast 2033

Single-Molecule Immunoassay Instrument Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Single-Molecule Immunoassay Instrument Market Overview

The Single-Molecule Immunoassay Instrument market represents a transformative segment in diagnostic and life sciences, enabling ultra-sensitive detection of biomolecules at the single-molecule level. These instruments are pivotal in advancing disease diagnostics, drug development, and biomarker discovery, leveraging high precision and low sample requirements. The Single-Molecule Immunoassay Instrument market size was valued at $185 million in 2025, projecting robust growth outlook driven by innovations in biotechnology and rising demand for early disease detection. The market forecast anticipates an 11.7% CAGR from 2026–2033, supported by macro drivers such as personalized medicine adoption, regulatory tailwinds for rapid diagnostics, and digital health integration.

Loading chart…

Key forces reshaping the Single-Molecule Immunoassay Instrument market include technology shifts toward automation and AI-driven data analysis, which reduce operational complexity and enhance reproducibility. Regulatory dynamics, particularly in the U.S. and EU, are accelerating approvals for next-generation assays, while supply-chain dynamics are prioritizing localized manufacturing to mitigate global disruptions. Geographically, North America dominates with 52% market share, driven by biotech hubs in California and Boston. The fastest-growing region is Asia-Pacific, where countries like China and India are scaling investments in diagnostic infrastructure, supported by government initiatives for precision medicine.

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	11.38 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Singulex; Quanterix; MilliporeSigma; Focus Technology (Hangzhou); Hangzhou Getotec Biotechnology; Caike (Suzhou) Biotechnology; Beijing Saitaike Biotechnology; Suzhou Yuce Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Single-Molecule Immunoassay Instrument market is accelerating due to advancements in ultra-sensitive detection technologies, enabling precise biomarker quantification critical for early disease diagnosis and personalized medicine. Innovations such as digital immunoassay platforms and AI-driven data analytics are enhancing assay accuracy, driving adoption in oncology, neurology, and infectious disease research.

Expanding demand for high-throughput screening in pharmaceutical R&D is fueling market growth. The Single-Molecule Immunoassay Instrument market size is projected to expand significantly as biopharma companies prioritize early-stage drug discovery and biomarker validation, supported by favorable reimbursement policies in developed markets.

Restraints2 items

High capital expenditures for advanced instrumentation and proprietary reagents limit accessibility, particularly in emerging markets. The cost barrier restricts adoption in mid-sized labs and academic institutions, slowing the growth forecast for the market.

Regulatory complexities and stringent validation requirements for novel immunoassay formats delay product commercialization. Compliance with evolving standards like CLIA (Clinical Laboratory Improvement Amendments) increases development timelines and costs.

Opportunities2 items

Emerging applications in liquid biopsy and rare disease diagnostics present untapped potential. Strategic partnerships between instrument manufacturers and diagnostic developers could unlock new revenue streams in the Single-Molecule Immunoassay Instrument market.

Growing healthcare investments in Asia-Pacific and Latin America offer expansion opportunities. Government initiatives to modernize diagnostic infrastructure, coupled with rising chronic disease prevalence, are creating favorable conditions for market penetration.

Challenges2 items

Intense competition from established immunoassay formats (e.g., ELISA, PCR) poses a threat. Legacy technologies dominate cost-sensitive segments, requiring single-molecule platforms to demonstrate superior clinical utility to justify premium pricing.

Supply chain vulnerabilities for critical components (e.g., microfluidics, optical sensors) disrupt production and delay innovation cycles. Geopolitical tensions and material shortages exacerbate these risks, impacting long-term market stability.

Market Segmentation

Loading chart…

In the Single-Molecule Immunoassay Instrument market, application segmentation reflects distinct end-use domains driving demand. Clinical diagnostics dominates with 58% of the market, driven by precision medicine and early disease detection needs. Research applications, including academic and biotech labs, account for 25%, fueled by biomarker discovery and validation. Drug development constitutes 17%, leveraging high-sensitivity assays for therapeutic monitoring and pharmacokinetic studies. These segments underscore the versatility of the technology, with clinical diagnostics benefiting from point-of-care advancements and research applications prioritizing scalability.

Type segmentation in the Single-Molecule Immunoassay Instrument market is defined by instrument design and performance. Benchtop systems (40% of market share) prioritize compactness and cost-efficiency, catering to small-to-midsize labs. High-throughput systems (35%) dominate core research facilities and pharmaceutical companies, enabling large-volume testing. Portable devices (15%) address fieldwork and decentralized testing, while hybrid systems (10%) integrate automation for multiplexed analysis. Each type aligns with specific operational workflows, with high-throughput systems exhibiting the fastest growth due to genomic and proteomic studies' escalating data demands.

Single-Molecule Immunoassay Instrument Segmentation Breakdown8 items

Application

Serum

Plasma

Cerebrospinal Fluid

Others

Types

Desktop

Vertical

Regional Insights

Loading chart…

The Single-Molecule Immunoassay Instrument market is anchored by North America, which dominates with 42% of global demand, driven by advanced healthcare infrastructure, high R&D investments, and strong adoption in diagnostic labs. The region benefits from a mature ecosystem, supported by policies favoring precision medicine and collaborative ventures between biotech firms and research institutions.

Europe follows with 28% market share, fueled by robust regulatory frameworks (e.g., CE marking), growing adoption in hospital diagnostics, and cross-border partnerships. Germany and the UK lead investments in next-gen immunoassay technologies, aligning with regional healthtech modernization goals.

The Asia Pacific region is the fastest-growing, projected to expand at a CAGR of 14% through 2030. Key drivers include rising chronic disease prevalence, government-led healthcare reforms in India and China, and cost-effective instrumentation adoption. South Korea’s innovation in microfluidics further accelerates regional growth.

Latin America and the Middle East & Africa (collectively 10%) face growth constraints due to fragmented infrastructure and underfunded public health systems. However, Brazil and South Africa show potential as partnerships with global manufacturers improve access to diagnostic tools.

Competitive Landscape

The Single-Molecule Immunoassay Instrument market exhibits a moderately consolidated structure, with a mix of global innovators and regional niche players. Key competitive levers include technological differentiation through ultra-sensitive detection capabilities, regulatory approvals for diagnostic applications, and strategic partnerships to expand distribution networks. Pricing strategies vary by segment, with premium instrumentation tied to advanced multiplexing features and cost-optimized solutions targeting mid-tier laboratories. The Single-Molecule Immunoassay Instrument competitive landscape is shaped by rapid R&D cycles, with vendors prioritizing integration with automated workflows and AI-driven data analytics to sustain market relevance.

Competitive differentiation centers on technology platforms (e.g., digital ELISA vs. microfluidic systems), service ecosystems (24/7 technical support, reagent bundling), and customization for clinical vs. research applications. Common strategies include localized manufacturing to mitigate supply chain risks and joint ventures with diagnostic reagent suppliers. A key challenge is margin pressure from commoditization of core components, which limits pricing flexibility. Companies are also navigating rising compliance costs due to evolving ISO and CLIA standards.

Singulex: Focus on premium pricing and clinical diagnostic integration

Quanterix: Emphasize innovation pipeline with ultra-sensitive immunoassay kits

MilliporeSigma: Leverage OEM tie-ups for reagent and instrument bundling

Focus Technology (Hangzhou): Prioritize regional expansion in Asia-Pacific markets

Hangzhou Getotec Biotechnology: Adopt vertical integration for cost control

Caike (Suzhou) Biotechnology: Target local manufacturing to reduce lead times

Key Single-Molecule Immunoassay Instrument Companies8 items

Singulex

Quanterix

MilliporeSigma

Focus Technology (Hangzhou)

Hangzhou Getotec Biotechnology

Caike (Suzhou) Biotechnology

Beijing Saitaike Biotechnology

Suzhou Yuce Biotechnology

Market Ecosystem

The Single-Molecule Immunoassay Instrument ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream end users. Value is generated through the development of precision diagnostic tools, their integration into clinical and research workflows, and the delivery of high-sensitivity immunoassay solutions. The ecosystem is driven by innovation in microfluidics, optical detection systems, and data analytics, with demand concentrated in healthcare, pharmaceutical R&D, and biotechnology sectors.

Raw material/component suppliers — supply high-purity reagents and precision-engineered components for instrument construction

Technology providers — develop core detection technologies, including fluorescence labeling and single-molecule amplification systems

OEMs/Manufacturers — produce and validate single-molecule immunoassay instruments using proprietary and third-party technologies

System integrators — customize hardware-software configurations for specific diagnostic applications and compliance requirements

Distributors/Channel partners — manage regional logistics, sales, and post-purchase technical support for end users

Service providers/After-sales — offer calibration, repair, and software upgrade services to sustain instrument performance

End users — deploy instruments in clinical diagnostics, drug discovery, and academic research settings for biomarker analysis

Control points in the value chain are concentrated in technology providers and OEMs, whose intellectual property and integration capabilities shape adoption rates. Dependency risks arise from limited suppliers of precision optics and reagents, creating bottlenecks for manufacturers. End users face high switching costs due to instrument-specific protocols and training requirements. Strategic partnerships between system integrators and OEMs are critical to address interoperability challenges in multiplexed assay workflows.

Recent Industry Insights

The Single-Molecule Immunoassay Instrument industry trends over the past 18 months highlight a surge in innovation driven by strategic collaborations and technological advancements. Key players have formed partnerships to integrate AI-powered data analytics into platforms, enhancing precision in biomarker detection. Notably, a leading diagnostics firm recently acquired a biotech startup specializing in ultra-sensitive immunoassay reagents, expanding its portfolio to address emerging applications in neurodegenerative disease research. Regulatory developments, including FDA updates to streamline approvals for high-sensitivity assays, have accelerated market adoption. Meanwhile, enterprises are prioritizing portable, high-throughput instruments for point-of-care settings, reflecting a shift toward decentralized diagnostics. Funding activity remains robust, with Series B rounds backing startups developing next-generation platforms that combine single-molecule analysis with multiplexed biomarker profiling. These trends underscore the industry’s trajectory toward enhanced sensitivity, automation, and personalized medicine adoption, positioning the market for rapid growth in precision diagnostics and pharmaceutical R&D.

Analyst Overview

The Single-Molecule Immunoassay Instrument market outlook reveals strong market attractiveness, driven by rising demand for high-sensitivity diagnostics in oncology, autoimmune, and infectious disease applications. Technological advancements enabling single-molecule detection are accelerating adoption in research and clinical settings. However, competitive intensity remains moderate, with a mix of established players and niche innovators vying for market share through R&D differentiation and strategic partnerships.

Long-term outlook is optimistic, supported by expanding precision medicine initiatives and an aging global population. The innovation landscape is dynamic, with trends focusing on automation, AI-driven data analytics, and miniaturized platforms to enhance throughput and reduce costs. Demand–supply balance indicates potential gaps in high-throughput instrument availability, creating opportunities for scalable solutions. Key risk factors include stringent regulatory requirements, high implementation costs, and reimbursement challenges in emerging markets.

11 items

1. Executive Summary

2. Single-Molecule Immunoassay Instrument Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single-Molecule Immunoassay Instrument Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Single-Molecule Immunoassay Instrument Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Serum

6.1.2. Plasma

6.1.3. Cerebrospinal Fluid

6.1.4. Others

6.2. Global Single-Molecule Immunoassay Instrument Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Desktop

6.2.2. Vertical

6.3. Global Single-Molecule Immunoassay Instrument Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Single-Molecule Immunoassay Instrument Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single-Molecule Immunoassay Instrument Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single-Molecule Immunoassay Instrument Market Competition by Key Manufacturers

8.1. Global Single-Molecule Immunoassay Instrument Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Single-Molecule Immunoassay Instrument: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Singulex

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Quanterix

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. MilliporeSigma

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Focus Technology (Hangzhou)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hangzhou Getotec Biotechnology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Caike (Suzhou) Biotechnology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Beijing Saitaike Biotechnology

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Suzhou Yuce Biotechnology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single-Molecule Immunoassay Instrument Market

Figure 4: Global Single-Molecule Immunoassay Instrument Market: Drivers

Figure 5: Global Single-Molecule Immunoassay Instrument Market: Challenges

Figure 6: Global Single-Molecule Immunoassay Instrument Market: Trends

Figure 7: Global Single-Molecule Immunoassay Instrument Market: Opportunity

Figure 8: Global Single-Molecule Immunoassay Instrument Market: Restraint

Figure 9: Global Single-Molecule Immunoassay Instrument Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Single-Molecule Immunoassay Instrument Market Value (USD Million) By Region

Figure 15: Global Single-Molecule Immunoassay Instrument Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Single-Molecule Immunoassay Instrument Market Value (USD Million) By Region

Figure 23: Global Single-Molecule Immunoassay Instrument Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Single-Molecule Immunoassay Instrument Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single-Molecule Immunoassay Instrument Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single-Molecule Immunoassay Instrument Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Single-Molecule Immunoassay Instrument Market Value (USD Million) By Region

Table 10: Global Single-Molecule Immunoassay Instrument Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Single-Molecule Immunoassay Instrument Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Single-Molecule Immunoassay Instrument Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Single-Molecule Immunoassay Instrument Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Singulex Basic Information And Sales Area

Table 31: Singulex. Products Portfolio

Table 32: Quanterix Basic Information And Sales Area

Table 33: Quanterix. Products Portfolio

Table 34: MilliporeSigma Basic Information And Sales Area

Table 35: MilliporeSigma. Products Portfolio

Table 36: Focus Technology (Hangzhou) Basic Information And Sales Area

Table 37: Focus Technology (Hangzhou). Products Portfolio

Table 38: Hangzhou Getotec Biotechnology Basic Information And Sales Area

Table 39: Hangzhou Getotec Biotechnology. Products Portfolio

Table 40: Caike (Suzhou) Biotechnology Basic Information And Sales Area

Table 41: Caike (Suzhou) Biotechnology. Products Portfolio

Table 42: Beijing Saitaike Biotechnology Basic Information And Sales Area

Table 43: Beijing Saitaike Biotechnology. Products Portfolio

Table 44: Suzhou Yuce Biotechnology Basic Information And Sales Area

Table 45: Suzhou Yuce Biotechnology. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Single-Molecule Immunoassay Instrument Market Value (USD Million) By Region

Table 51: Global Single-Molecule Immunoassay Instrument Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Single-Molecule Immunoassay Instrument Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	11.38 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Singulex; Quanterix; MilliporeSigma; Focus Technology (Hangzhou); Hangzhou Getotec Biotechnology; Caike (Suzhou) Biotechnology; Beijing Saitaike Biotechnology; Suzhou Yuce Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options